Satterlee W - Search Results

1

The location of middle mediastinal pheochromocytomas.

Shapiro B, Sisson J, Kalff V, Glowniak J, Satterlee W, Glazer G, Francis I, Bowers R, Thompson N, Orringer M, et al. Shapiro B, et al. Among authors: satterlee w. J Thorac Cardiovasc Surg. 1984 Jun;87(6):814-20. J Thorac Cardiovasc Surg. 1984. PMID: 6727403

2

Radiopharmaceutical treatment of malignant pheochromocytoma.

Sisson JC, Shapiro B, Beierwaltes WH, Glowniak JV, Nakajo M, Mangner TJ, Carey JE, Swanson DP, Copp JE, Satterlee WG, et al. Sisson JC, et al. Among authors: satterlee wg. J Nucl Med. 1984 Feb;25(2):197-206. J Nucl Med. 1984. PMID: 6726430 Free article.

3

Treatment of malignant pheochromocytoma with a new radiopharmaceutical.

Sisson J, Shapiro B, Beierwaltes WH, Nakajo M, Glowniak J, Mangner T, Carey JE, Swanson DP, Copp J, Satterlee W, et al. Sisson J, et al. Among authors: satterlee w. Trans Assoc Am Physicians. 1983;96:209-17. Trans Assoc Am Physicians. 1983. PMID: 6679954

4

Malignant phaeochromocytoma: clinical, biochemical and scintigraphic characterization.

Shapiro B, Sisson JC, Lloyd R, Nakajo M, Satterlee W, Beierwaltes WH. Shapiro B, et al. Among authors: satterlee w. Clin Endocrinol (Oxf). 1984 Feb;20(2):189-203. doi: 10.1111/j.1365-2265.1984.tb00074.x. Clin Endocrinol (Oxf). 1984. PMID: 6713689 Free article.

5

Liver-spleen studies with the rotating gamma camera. II: Utility of tomography.

Keyes JW Jr, Singer D, Satterlee W, Kalff V, Harkness BA. Keyes JW Jr, et al. Among authors: satterlee w. Radiology. 1984 Nov;153(2):537-41. doi: 10.1148/radiology.153.2.6484184. Radiology. 1984. PMID: 6484184

6

Liver-spleen studies with the rotating gamma camera. I: Utility of the rotating display.

Kalff V, Satterlee W, Harkness BA, Singer D, Keyes JW Jr. Kalff V, et al. Among authors: satterlee w. Radiology. 1984 Nov;153(2):533-6. doi: 10.1148/radiology.153.2.6333047. Radiology. 1984. PMID: 6333047

7

Sequential use of indium-111 labeled monoclonal antibodies 96.5 and ZME-018 does not increase detection sensitivity for metastatic melanoma.

Frontiera M, Murray JL, Lamki L, Thomas J, Satterlee W, Schmelter R, Rosenblum MG, Khazaeli MB, Unger MW, Robinson WA, et al. Frontiera M, et al. Among authors: satterlee w. Clin Nucl Med. 1989 May;14(5):357-66. doi: 10.1097/00003072-198905000-00011. Clin Nucl Med. 1989. PMID: 2656042 Clinical Trial.

8

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.

Abbruzzese JL, Grunewald R, Weeks EA, Gravel D, Adams T, Nowak B, Mineishi S, Tarassoff P, Satterlee W, Raber MN, et al. Abbruzzese JL, et al. Among authors: satterlee w. J Clin Oncol. 1991 Mar;9(3):491-8. doi: 10.1200/JCO.1991.9.3.491. J Clin Oncol. 1991. PMID: 1999720 Clinical Trial.

9

Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days.

O'Rourke TJ, Brown TD, Havlin K, Kuhn JG, Craig JB, Burris HA, Satterlee WG, Tarassoff PG, Von Hoff DD. O'Rourke TJ, et al. Among authors: satterlee wg. Eur J Cancer. 1994;30A(3):417-8. doi: 10.1016/0959-8049(94)90276-3. Eur J Cancer. 1994. PMID: 8204374 Clinical Trial. No abstract available.

10

Clinical pharmacology of a novel diarylsulfonylurea anticancer agent.

Taylor CW, Alberts DS, Ketcham MA, Satterlee WG, Holdsworth MT, Plezia PM, Peng YM, McCloskey TM, Roe DJ, Hamilton M, et al. Taylor CW, et al. Among authors: satterlee wg. J Clin Oncol. 1989 Nov;7(11):1733-40. doi: 10.1200/JCO.1989.7.11.1733. J Clin Oncol. 1989. PMID: 2809686

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters